Literature DB >> 22858587

Increased serum IL-33 levels may indicate vascular involvement in systemic sclerosis.

Sarah Terras, Elisabeth Opitz, Rose K C Moritz, Stefan Höxtermann, Thilo Gambichler, Alexander Kreuter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22858587     DOI： 10.1136/annrheumdis-2012-201553

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  13 in total

1.  Early systemic sclerosis: serum profiling of factors involved in endothelial, T-cell, and fibroblast interplay is marked by elevated interleukin-33 levels.

Authors:  Serena Vettori; Giovanna Cuomo; Michele Iudici; Virginia D'Abrosca; Veronica Giacco; Giusi Barra; Raffaele De Palma; Gabriele Valentini
Journal:  J Clin Immunol       Date:  2014-04-24       Impact factor: 8.317

Review 2.  Emerging role of interleukin-33 in autoimmune diseases.

Authors:  Cheng Pei; Mark Barbour; Karen J Fairlie-Clarke; Debbie Allan; Rong Mu; Hui-Rong Jiang
Journal:  Immunology       Date:  2014-01       Impact factor: 7.397

3.  Association of interleukin 1 family with systemic sclerosis.

Authors:  Li Zhang; Jun-Wei Yan; Yu-Jie Wang; Ya-Nan Wan; Bing-Xiang Wang; Jin-Hui Tao; Bing Chen; Bao-Zhu Li; Guo-Jun Yang; Jing Wang
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

4.  Association of interleukin-1 family cytokines single nucleotide polymorphisms with susceptibility to systemic sclerosis: an independent case-control study and a meta-analysis.

Authors:  Xiao-Lei Huang; Guo-Cui Wu; Yu-Jie Wang; Xiao-Ke Yang; Guo-Jun Yang; Jin-Hui Tao; Yu Duan; Jun-Wei Yan; Xiang-Pei Li; Dong-Qing Ye; Jing Wang
Journal:  Immunol Res       Date:  2016-08       Impact factor: 2.829

5.  Red Blood Cells Store and Release Interleukin-33.

Authors:  Jianxin Wei; Jing Zhao; Valerie Schrott; Yingze Zhang; Mark Gladwin; Grant Bullock; Yutong Zhao
Journal:  J Investig Med       Date:  2015-08       Impact factor: 2.895

6.  Elevated serum levels of interleukin-1β and interleukin-33 in patients with systemic sclerosis in Chinese population.

Authors:  Y-J Zhang; Q Zhang; G-J Yang; J-H Tao; G-C Wu; X-L Huang; Y Duan; X-P Li; D-Q Ye; J Wang
Journal:  Z Rheumatol       Date:  2018-03       Impact factor: 1.372

7.  The IL-33 gene is related to increased susceptibility to systemic sclerosis.

Authors:  Suleyman Serdar Koca; Yavuz Pehlivan; Murat Kara; Fatma Alibaz-Oner; Serdar Oztuzcu; Neslihan Yilmaz; Gozde Yildirim Cetin; Bunyamin Kisacik; Metin Ozgen; Omer Nuri Pamuk; Haner Direskeneli; Mehmet Sayarlioglu; Ahmet Mesut Onat
Journal:  Rheumatol Int       Date:  2016-01-07       Impact factor: 2.631

Review 8.  The role of IL-33 in rheumatic diseases.

Authors:  Lihua Duan; Jie Chen; Feili Gong; Guixiu Shi
Journal:  Clin Dev Immunol       Date:  2013-09-15

Review 9.  Interleukin-33 in Systemic Sclerosis: Expression and Pathogenesis.

Authors:  Liya Li; Honglin Zhu; Xiaoxia Zuo
Journal:  Front Immunol       Date:  2018-11-15       Impact factor: 7.561

Review 10.  The Roles of IL-1 Family Cytokines in the Pathogenesis of Systemic Sclerosis.

Authors:  Dan Xu; Rong Mu; Xiaofan Wei
Journal:  Front Immunol       Date:  2019-09-13       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.